These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2005-000086-19 ''An Open Label Evaluation of Long Term Efficacy and Safety of Posterior Justascleral Injections of Anecortave Acetate 15 mg in Patients with Subfoveal Exudative Age-Related Macular Degeneration (AMD)... 2008-10-19 due-trials
Reported results 2005-001179-36 Efficacy and safety of Dexa-Polyspectran® drops, preserved with benzalkonium chloride, vs. Dexa-Polyspectran® drops without dexamethasone phosphate, preserved with benzalkonium chloride, in patients w... 2007-06-08 due-trials
Reported results 2005-001180-65 Efficacy and safety of Polyspectran® drops, preserved with benzalkonium chloride vs. glycerol ear drops in patients with acute bacterial otitis externa – A double-blind, multicenter, prospective, ran... 2007-07-06 due-trials
Reported results 2005-001598-93 An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study “A”... 2009-11-13 due-trials
Completed, but no date, and reported results 2005-001786-34 Hypotonic efficacy and tollerability of Travoprost in patient with open angle primary glaucoma and/or ocular hypertension, not controlled with dorzolamide + timolol treatment in fixed association, o... bad-data
Completed, but no date, and reported results 2005-002252-18 Hypotonic efficacy and tollerability of Travoprost in patient with glaucoma or ocular hypertension, monotherapy or fixed association beta-blocking not controlled or intollerant. bad-data
Reported results 2005-002647-35 Nepafenac 0.1 Eye Drops, Suspension compared to Ketorolac Trometamol 0.5 Eye Drops, Solution and Placebo Nepafenac Vehicle for the Prevention and Treatment of Ocular Inflammation and Ocular pain a... 2006-10-03 due-trials
Completed, but no date, and reported results Terminated 2005-004201-29 THE EFFICACY AND SAFETY OF TIMOLOL MALEATE 0.5% COMPARED TO BRINZOLAMIDE 1% EACH GIVEN TWICE DAILY WHEN ADDED TO TRAVOPROST 0.004% GIVEN EACH EVENING IN PRIMARY OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENS... bad-data
Reported results 2005-004766-16 Comparison of Safety and Efficacy of Brinzolamide/Timolol Fixed Combination vs COSOPT in Patients with Open-Angle Glaucoma or Ocular Hypertension 2007-08-30 due-trials
Reported results 2005-004767-34 A Six-Week, Multicenter, Randomized, Double-Masked Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of Travoprost 0.004 /Timolol 0.5 Once-Daily Morning Dosing and Once-Daily Evening ... 2007-05-31 due-trials
Completed, but no date, and reported results 2005-004768-22 Clinical study of the mast-cell stabilizing effects of the Olopatadine using the Conjunctival Allergen Challeenge model bad-data
Completed, but no date, and reported results Terminated 2006-000071-15 Study of the Efficacy and Safety of Travatan Therapy compared with Cosopt Therapy in Patients with Open-Angle Glaucoma or Ocular Hypertension. bad-data
Reported results 2006-003356-38 A Study of the Safety and Efficacy of Anecortave Acetate for Treatment of Steroid Induced IOP Elevation 2009-09-07 due-trials
Completed, but no date, and reported results 2006-003627-37 Hypotonic efficacy and tollerability of concomitant supply of Travoprost e Brinzolamide vs dorzolamide-timololo in fixed association in patient with glaucoma or ocular hypertension clinical study, mu... bad-data
Reported results 2006-005237-38 SAFETY AND EFFICACY OF SWITCHING TO THE TRAVOPROST/TIMOLOL MALEATE FIXED COMBINATION (DUOTRAV) FROM PRIOR MONO- OR TWO-DRUG THERAPY IN GERMANY 2008-12-17 due-trials
Completed, but no date, and reported results 2007-000515-29 Adherencia de los pacientes en el uso de Travalert® para la instilación de una combinación fija de travoprost 0.004% / timolol 0.5% comparado con un régimen concomitante de travoprost 0.004% y timolol... bad-data
Reported results 2007-002501-45 Phase IV randomised double masked clinical trial: Assessing morning versus evening dosing of a fixed dose combination of Travoprost 0.004% / Timolol Maleate 0.5% in patients with primary open angle gl... 2010-10-01 due-trials
Completed, but no date, and reported results 2007-004212-31 A Double-Masked, Multiple-Dose, Study of the IOP-Lowering Efficacy of Brinzolamide 1.0% Compared to Placebo When Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy in Prim... bad-data
Reported results 2007-005936-99 Effects of Topical Hypotensive Drugs on Circadian Ocular Perfusion Pressure and Ocular Blood Flow in Patients with Open-Angle Glaucoma 2012-01-31 due-trials
Completed, but no date, and reported results Terminated 2008-002750-38 24-hour IOP control with Travoprost / Brinzolamide fixed combination once-daily (QD)in the evening vs TRAVATAN bad-data
Reported results 2008-002760-34 A Multi-Center, Double-Masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN® in Patients with Open-Angle Glaucoma or Ocular Hypertension 2009-09-17 due-trials
Reported results 2008-002780-13 A Three-Month, Multicenter, Double-Masked Study Comparing the Safety and Efficacy of the Fixed Combination Travoprost + Brinzolamide Eye Drops, Suspension vs Travatan vs Azopt in Patients with Open-An... 2009-02-17 due-trials
Reported results 2008-002781-66 A twelve-month, multicenter, double-masked study of Travoprost / Brinzolamide fixed combination QD AM and Travoprost / Brinzolamide fixed combination QD PM versus COSOPT BID in patients with open-angl... 2009-01-27 due-trials
Reported results Terminated 2008-004862-24 An open-label exploratory study to assess the safety, tolerability and clinical activity of topically applied ESBA105 in patients with acute anterior uveitis 2010-12-14 due-trials
Reported results 2008-006027-31 A Multi-Center Double-Masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN in Patients with Open-Angle Glaucoma or Ocular Hypertension 2010-01-28 due-trials
Reported results 2008-006718-10 The Efficacy and Safety of Travoprost 0.004% versus Tafluprost 0.005% in Primary Open-Angle Glaucoma or Ocular Hypertensive Patients. 2010-03-02 due-trials
Reported results 2008-007705-37 The Safety and Efficacy of AL-8309B Ophtalmic Solution for the treatment of Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) 2012-05-31 due-trials
Reported results 2009-010101-36 The Efficacy and Safety of Adding the Brinzolamide/Timolol Maleate Fixed Combination (Azarga®) to Prostaglandin Monotherapy 2010-08-27 due-trials
Reported results 2009-010536-17 A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle Following Cataract Surgery in Diabetic Retinopathy Patients 2011-11-04 due-trials
Reported results 2009-010604-29 An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution 2011-05-18 due-trials
Reported results 2009-010606-10 An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using Travoprost APS Eye Drops Solution Versus XALATAN Eye Drops Solution 2011-05-25 due-trials
Reported results 2009-010834-23 A multi-center, double-masked study of the safety and efficacy of DuoTrav APS compared to DuoTrav in patients with open-angle glaucoma or ocular hypertension 2009-05-01 due-trials
Reported results Terminated 2009-011036-36 Estudio multicéntrico de la pigmentación en la red trabecular después de dos años de tratamiento con TRAVATAN 0,004% solución oftálmica. A multicenter study of the pigmentation in the trabecular meshw... 2012-05-30 due-trials
Reported results 2009-013178-42 A Twelve-Month Open-Label Safety Study of Polyquaternium-Preserved DuoTrav APS Dosed Once Daily in Patients with Open-Angle Glaucoma or Ocular Hypertension 2010-11-01 due-trials
Reported results 2009-015681-55 A Dose-Escalation Study of AL-39324 Suspension versus Lucentis™ for the Treatment of Exudative Age-Related Macular Degeneration 2011-06-20 due-trials
Completed, but no date, and reported results 2009-015795-10 Assessing the safety and efficacy of switching to Azarga (Brinzolamide/Timolol Fixed Combination), as replacement therapy in patients with uncontrolled intraocular pressure bad-data
Reported results 2009-015796-27 Patient Preference Comparison of Azarga versus Cosopt, after Single Doses in Patients with Open-Angled Glaucoma or Ocular Hypertension 2011-05-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-017319-13 Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes 2011-10-14 bad-data
Reported results 2010-019507-28 Clinical Evaluation of Nepafenac Ophthalmic Suspension, 0.3% for Prevention and Treatment of Ocular Inflammation and Pain after Cataract Surgery 2011-05-25 due-trials
Reported results 2010-021973-35 Assessing the Safety and Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% Fixed Combination), as Replacement Therapy in Patients Uncontrolled on Bimatoprost 0.03%/Timolol 0.5% Therapy ... 2011-03-31 due-trials
Reported results 2010-022948-21 Efficacy and Safety of Adding the Brinzolamide/Timolol Maleate Fixed Combination (Azarga®) in Ocular Hypertensive or Glaucoma Patients Uncontrolled on Prostaglandin Monotherapy 2013-04-08 due-trials
Reported results 2010-024244-15 "Patient Preference Comparison of Azarga versus Cosopt, in Patients with Open-Angle Glaucoma or Ocular Hypertension." 2012-10-13 due-trials
Reported results 2010-024512-34 Safety and IOP-Lowering Efficacy of Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL Fixed Combination Eye Drops, Suspension compared to Brinzolamide 10 mg/mL Eye Drops, Suspension and Brimonidine 2 mg/mL ... 2013-01-18 due-trials
Reported results 2010-024513-31 Efficacy and Safety of Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL Eye Drops, Suspension Compared to Brinzolamide 10 mg/mL Eye Drops, Suspension plus Brimonidine 2 mg/mL Eye Drops, Solution in Patie... 2013-01-29 due-trials
Reported results 2011-000161-13 Assessing the Efficacy and Tolerability of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination), as Replacement Therapy in Patients Previously on Bimatoprost 0.03%/Timolol ... 2012-11-19 due-trials
Exempt, with results 2011-000536-28 Safety and efficacy study with ESBA1008 versus Lucentis for the treatment of exudative age-related macular degeneration 2013-03-29 not-yet-due
Reported results 2011-003816-21 Multi-Center Study Assessing Efficacy and Tolerability of TRAVATAN Solution without BAK, containing Polyquad Preservative (0.004 travoprost) in Patients Previously on latanoprost 0.005 or bimatopros... 2013-02-12 due-trials
Reported results Terminated 2011-003851-20 A Multicente, Observer-Masked Study of the Safety and Efficacy of MDPF Travoprost, 0.004% Compared to TRAVATAN in Patients with Open-Angle Glaucoma or Ocular Hypertension 2012-02-02 due-trials
Reported results 2011-004587-29 A Multicenter, Double-Masked Study of the Safety and Efficacy of Travoprost Ophthalmic Solution, 0.003% Compared to TRAVATAN in Patients with Open-Angle Glaucoma or Ocular Hypertension 2012-08-28 due-trials
Reported results 2012-001324-34 A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients 2014-03-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-001640-22 An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients 2013-07-10 bad-data
Reported results 2012-002078-30 Assessing the Efficacy and Tolerability of TRAVATAN® Solution without BAK, containing Polyquad® Preservative (travoprost 0.004%) versus LUMIGAN® 0.01% Solution with BAK (bimatoprost 0.01%) in Treatme... 2014-06-18 due-trials
Reported results 2013-001874-12 Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation To Assess The Safety And Efficacy Of Nepafenac Ophthalmic Suspension, 0.3% For Improvement In Clinical Outcomes Among Diabetic Subjec... 2015-05-28 due-trials
Reported results 2013-005464-25 Assessment of Anatomical and Functional Outcomes in Patients Treated with Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (VMT/sVMA) 2015-09-02 due-trials
Completed, but no date Terminated 2014-004778-41 Assessment of Anatomical and Functional Outcomes in Subjects Treated with Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (VMT/sVMA) bad-data
Reported results 2014-004886-26 A Two-Year, Randomized, Double-Masked, Multicenter, Two-Arm Study Comparing the Efficacy and Safety of RTH258 6mg Versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration 2018-03-08 due-trials
Reported results 2015-000736-15 Additive Effect of Twice Daily Brinzolamide 1% /Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue 2018-02-27 due-trials
Reported results 2016-000176-20 Safety and Efficacy with Twice Daily Brinzolamide 1% / Brimonidine 0.2% (SIMBRINZA) as an Adjunctive Therapy to Travoprost 0.004% / Timolol 0.5% (DUOTRAV) 2018-07-31 due-trials
Trial is outside EEC, and reported results 2016-004317-27 A Comparative Study of Olopatadine Hydrochloride Ophthalmic Solution 0.2% QD vs Olopatadine Hydrochloride Ophthalmic Solution 0.1% BID in the Treatment of Allergic Conjunctivitis in Chinese Subjects bad-data
Trial is outside EEC, and reported results 2017-002689-30 Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes bad-data
Trial is outside EEC, and reported results 2017-002726-20 Safety of PATANASE® Nasal Spray in Patients With Perennial Allergic Rhinitis bad-data
Trial is outside EEC, and reported results 2017-002727-24 An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients bad-data
Trial is outside EEC, and reported results 2017-002728-26 A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of olopatadine hydrochloride (AL-4943A) Ophthalmic Solution 0.77% Administered Once Daily bad-data
Trial is outside EEC, and reported results 2017-002729-39 An Evaluation of the Safety and Efficacy of Moxifloxacin AF Ophthalmic Solution 0.5% for the Treatment of Bacterial Conjunctivitis in the USA bad-data
Trial is outside EEC, and reported results 2017-002730-23 An Evaluation of the Safety and Efficacy of Moxifloxacin AF Ophthalmic Solution 0.5% for the Treatment of Bacterial Conjunctivitis in the USA bad-data
Trial is outside EEC, and reported results 2017-002732-17 An evaluation of Moxidex Ophthalmic Solution for the treatment of marginal corneal infiltrates. bad-data
Trial is outside EEC, and reported results 2017-003841-39 Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Paediatric Patients bad-data
Trial is outside EEC, and reported results 2017-003846-26 Safety Study of Olopatadine Nasal Spray bad-data
Trial is outside EEC, and reported results 2017-003856-22 Safety and Efficacy of Olopatadine Hydrochloride Nasal Spray in 6-11 Year old Patients. bad-data
Trial is outside EEC, and reported results 2017-003953-41 An Open-label, Long-term Study, with AL-4943A Ophthalmic Solution, 0.2% in Patients with Allergic Conjunctivitis bad-data
Trial is outside EEC, and reported results 2017-003970-16 Safety and Pharmacokinetics of PATANASE in Paediatric Patients 2 to < 6 Years of Age with a history of allergic rhinitis bad-data
Trial is outside EEC, and reported results 2018-000615-25 Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Externa bad-data
Trial is outside EEC, and reported results 2018-000640-26 Safety and Efficacy Evaluation of Topical Moxidex Otic Solution Compared to Moxifloxacin Solution in the Treatment of Acute Otitis Media with Otorrhea through Tympanostomy Tubes (AOMT) bad-data
Trial is outside EEC, and reported results 2018-000641-39 Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Externa (AOE) bad-data
Trial is outside EEC, and reported results 2018-000642-19 Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Peri-Operative Tube Otorrhea bad-data
Trial is outside EEC, and reported results 2018-000643-37 Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes bad-data